| Serial Number | 90838630 |
| Word Mark | VELAVIGO |
| Filing Date | Tuesday, July 20, 2021 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, December 12, 2023 |
| Registration Number | 7238766 |
| Registration Date | Tuesday, December 12, 2023 |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, June 27, 2023 |
| Goods and Services | Chemical preparations for medical purposes used for treating tumors, ophthalmology diseases, cardiovascular diseases, immune diseases, metabolic diseases, blood diseases, diabetes, endocrine system diseases, reproductive system diseases, respiratory system diseases, central and peripheral nervous system diseases, cancer, autoimmune diseases, inflammation and antivirals; bulk drugs in the nature of pharmaceutical preparations, namely, for treating tumors, ophthalmology diseases, cardiovascular diseases, immune diseases, metabolic diseases, blood diseases, diabetes, endocrine system diseases, reproductive system diseases, respiratory system diseases, central and peripheral nervous system diseases, cancer, autoimmune diseases, inflammation and antivirals; diagnostic preparations for medical purposes; biochemical medicines, namely, for use in treating tumors, ophthalmology diseases, cardiovascular diseases, immune diseases, metabolic diseases, blood diseases, diabetes, endocrine system diseases, reproductive system diseases, respiratory system diseases, central and peripheral nervous system diseases, cancer, autoimmune diseases, inflammation and antivirals; diagnostic biomarker reagents for medical purposes; medicines for human purposes used for treating tumors, ophthalmology diseases, cardiovascular diseases, immune diseases, metabolic diseases, blood diseases, diabetes, endocrine system diseases, reproductive system diseases, respiratory system diseases, central and peripheral nervous system diseases, cancer, autoimmune diseases, inflammation and antivirals; pharmaceutical preparations used for treating tumors, ophthalmology diseases, cardiovascular diseases, immune diseases, metabolic diseases, blood diseases, diabetes, endocrine system diseases, reproductive system diseases, respiratory system diseases, central and peripheral nervous system diseases, cancer, autoimmune diseases, inflammation and antivirals; chemico-pharmaceutical preparations used for treating tumors, ophthalmology diseases, cardiovascular diseases, immune diseases, metabolic diseases, blood diseases, diabetes, endocrine system diseases, reproductive system diseases, respiratory system diseases, central and peripheral nervous system diseases, cancer, autoimmune diseases, inflammation and antivirals; drugs in the nature of pharmaceutical preparations for medical purposes used for treating tumors, ophthalmology diseases, cardiovascular diseases, immune diseases, metabolic diseases, blood diseases, diabetes, endocrine system diseases, reproductive system diseases, respiratory system diseases, central and peripheral nervous system diseases, cancer, autoimmune diseases, inflammation and antivirals; biological preparations for medical purposes used for treating tumors, ophthalmology diseases, cardiovascular diseases, immune diseases, metabolic diseases, blood diseases, diabetes, endocrine system diseases, reproductive system diseases, respiratory system diseases, central and peripheral nervous system diseases, autoimmune diseases, inflammation, cancer, and antivirals; chemical preparations for pharmaceutical purposes used for treating tumors, ophthalmology diseases, cardiovascular diseases, immune diseases, metabolic diseases, blood diseases, diabetes, endocrine system diseases, reproductive system diseases, respiratory system diseases, central and peripheral nervous system diseases, autoimmune diseases, inflammation, cancer, and antivirals; radioactive substances for medical purposes; gases for medical purposes; chemical conductors for electrocardiograph electrodes; semen for artificial insemination; disinfectants; solutions for contact lenses; media for bacteriological cultures; medicated sweets; dietetic foods and beverages adapted for medical use; depuratives for the body; pesticides; sanitary napkins; cotton for medical purposes; dental abrasives; diapers for pets |
| Goods and Services | Publicity services; marketing services, namely, presentation of goods on communication media, for retail purposes; business management assistance; marketing; personnel recruitment; compilation of information into computer databases; accounting; sponsorship search; rental of vending machines; rental of sales stands; retail store services featuring pharmaceutical, veterinary and sanitary preparations and medical supplies; wholesale store services featuring pharmaceutical, veterinary and sanitary preparations and medical supplies; retail and wholesale store services for medicines; retail and wholesale store services for pharmaceutical preparations; retail and wholesale store services for sanitary preparations; retail and wholesale store services for medical supplies; retail and wholesale store services for veterinary medicines; retail and wholesale store services for veterinary preparations |
| Goods and Services | Medical screening; genetic testing for medical purposes; medical analysis services for the diagnosis of cancer; medical services for the treatment of skin cancer; performing diagnosis of diseases; pharmaceutical advice; mental health therapy services; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; convalescent home services; food nutrition consultation; beauty salon services; animal breeding; plant nursery services; opticians' services; rental of sanitation facilities |
| Goods and Services | Scientific research for medical purposes in the area of cancerous diseases; scientific investigations for medical purposes; quality control for others; surveying; chemical analysis; research in the field of chemistry; chemical research; chemical research services; chemical research and analysis; cosmetic research; biochemical research and analysis; conducting early evaluation in the field of new pharmaceuticals; drug discovery services; pharmaceutical product evaluation; pharmaceutical research services; research on the subject of pharmaceuticals; development of pharmaceutical preparations and medicines; research and development services in the field of antibodies; scientific research in the nature of conducting clinical trials for others; biotechnology research; biological research; biological research and analysis; biomedical research services; medical laboratory services; medical research; medical research services; meteorological information; material testing; industrial design; architectural services; dress designing; computer programming in the medical field; authenticating works of art; graphic arts design; cloud seeding; handwriting analysis; cartography services; rental of meters for the recording of energy consumption; business card design; graphic design of promotional materials |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, September 21, 2021 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 035 - Advertising; business management; business administration; office functions. |
| US Class Codes | 100, 101, 102 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, September 21, 2021 |
| Primary Code | 035 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, September 21, 2021 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, September 21, 2021 |
| Primary Code | 044 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | VELAVIGO (SHANGHAI) LIMITED |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 99 - Other |
| Address | SHANGHAI, PILOT FREE TRADE ZONE CN |
| Party Name | VELAVIGO (SHANGHAI) LIMITED |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 99 - Other |
| Address | SHANGHAI, PILOT FREE TRADE ZONE CN |
| Party Name | VELAVIGO (SHANGHAI) LIMITED |
| Party Type | 11 - New Owner Before Publication |
| Legal Entity Type | 99 - Other |
| Address | SHANGHAI, PILOT FREE TRADE ZONE CN |
| Party Name | NOT AVAILABLE |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 01 - Individual |
| Address | Lexington, MA 02420 |
| Event Date | Event Description |
| Tuesday, December 12, 2023 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| Tuesday, December 12, 2023 | REGISTERED-PRINCIPAL REGISTER |
| Sunday, November 5, 2023 | EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED |
| Monday, July 24, 2023 | EXTENSION OF TIME TO OPPOSE RECEIVED |
| Tuesday, June 27, 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, June 27, 2023 | PUBLISHED FOR OPPOSITION |
| Wednesday, June 7, 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, May 23, 2023 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
| Monday, May 15, 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Friday, May 12, 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Friday, May 12, 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, May 11, 2023 | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED |
| Tuesday, May 9, 2023 | SUSPENSION CHECKED ¿ TO ATTORNEY FOR ACTION |
| Wednesday, May 3, 2023 | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP |
| Wednesday, April 26, 2023 | SUSPENSION CHECKED ¿ TO ATTORNEY FOR ACTION |
| Wednesday, November 23, 2022 | ASSIGNED TO EXAMINER |
| Monday, October 24, 2022 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
| Monday, October 24, 2022 | LETTER OF SUSPENSION E-MAILED |
| Monday, October 24, 2022 | SUSPENSION LETTER WRITTEN |
| Thursday, October 20, 2022 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Thursday, October 20, 2022 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, October 20, 2022 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Thursday, April 21, 2022 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Thursday, April 21, 2022 | NON-FINAL ACTION E-MAILED |
| Thursday, April 21, 2022 | NON-FINAL ACTION WRITTEN |
| Tuesday, April 12, 2022 | ASSIGNED TO EXAMINER |
| Tuesday, October 5, 2021 | PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED |
| Monday, October 4, 2021 | ASSIGNED TO LIE |
| Tuesday, August 17, 2021 | TEAS VOLUNTARY AMENDMENT RECEIVED |
| Tuesday, September 21, 2021 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Friday, July 23, 2021 | NEW APPLICATION ENTERED |